Enovis Corporation announced it will release its third quarter 2026 financial results on November 5, 2026, followed by an investor conference call and live webcast at 8:30 a.m. Eastern Time. The company will issue an earnings press release earlier that morning, with the webcast and presentation accessible on its website. This event allows investors to hear directly from Enovis about its recent performance and outlook. Enovis is a medical technology company focused on innovative solutions to improve patient outcomes and surgical efficiency.
Enovis plans to release its third quarter 2026 results on November 5th. For readers following the health sector, here is Pluang's market snapshot as of Oct 08, 2026 18:43 WIB: out of 128 priced US health stocks, 29 rose and 91 fell. Notable movers include TXG (10X Genomics Inc) at USD 72.44 with a 1-day change of -4.81% and a typical hold time on Pluang of 92 days, with 74% sell orders; TWST (Twist Bioscience Corp) at USD 148.76, down 4.43%, typical hold time 27 days, with 97% buy orders; and DNA (Ginkgo Bioworks Holdings Inc) at USD 11.07, down 3.49%, typical hold time 7 days, with 58% buy orders.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
